Nontumor‐Specific mRNA Sensitization of Cold Tumors to Immune Checkpoint Blockade: Evidence, Bias, and Requirements for Translation
Advanced Oncology · 2026
DOI: 10.1002/adon.70007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Oncology, 2026. Verfasst von Sarfaraz K. Niazi. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Nontumor‐specific messenger RNA may sensitize cold tumors to checkpoint blockade, but survival estimates are heterogeneous, bias‐aligned analyses reveal no difference, and spreading is unproven.
Zitieren
APA
Niazi, S. K. (2026). Nontumor‐Specific mRNA Sensitization of Cold Tumors to Immune Checkpoint Blockade: Evidence, Bias, and Requirements for Translation. Advanced Oncology. https://doi.org/10.1002/adon.70007
Vancouver
Niazi SK. Nontumor‐Specific mRNA Sensitization of Cold Tumors to Immune Checkpoint Blockade: Evidence, Bias, and Requirements for Translation. Advanced Oncology. 2026. doi:10.1002/adon.70007
BibTeX
@article{Niazi2026,
author = {Niazi, Sarfaraz K.},
title = {Nontumor‐Specific mRNA Sensitization of Cold Tumors to Immune Checkpoint Blockade: Evidence, Bias, and Requirements for Translation},
journal = {Advanced Oncology},
year = {2026},
doi = {10.1002/adon.70007}
}
EUVIMED